
zzso cell lung cancer zzso is a major global health problem and represents the leading cause of zzso deaths zzso The majority of patients with zzso are diagnosed with zzso disease, and the prognosis for such patients is zzso The currently approved zzso chemotherapy is associated with substantial limitations in both efficacy and zzso The availability of agents targeted against the zzso growth factor zzso zzso as well as the zzso agent zzso have provided some clinical zzso Nonetheless, the efficacy of these agents is also zzso and resistance has emerged as a clinical zzso Numerous novel targeted therapies are now in clinical development and may have potential for overcoming the limitations associated with currently available zzso In this article we review clinical data for zzso therapies in zzso with emphasis on zzso zzso and zzso zzso 

